Published in Pediatr Res on February 01, 1995
Toward a new generation of vaccines: the anti-cytokine therapeutic vaccines. Proc Natl Acad Sci U S A (2001) 0.94
Development and remodeling of the vertebrate blood-gas barrier. Biomed Res Int (2012) 0.82
The role of maternally derived epidermal growth factor and the epidermal growth factor receptor during organogenesis in the rat embryo. J Anat (1997) 0.79
Upregulated expression of EGF and TGF-alpha in the proximal respiratory epithelium in the human hypoplastic lung in congenital diaphragmatic hernia. Pediatr Surg Int (2004) 0.77
Ventilation-induced increases in EGFR ligand mRNA are not altered by intra-amniotic LPS or ureaplasma in preterm lambs. PLoS One (2014) 0.76
CIMAvax-EGF: A New Therapeutic Vaccine for Advanced Non-Small Cell Lung Cancer Patients. Front Immunol (2017) 0.75
Brief mechanical ventilation causes differential epithelial repair along the airways of fetal, preterm lambs. Am J Physiol Lung Cell Mol Physiol (2016) 0.75
Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology (2001) 2.37
Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas. Endocrinology (1986) 1.80
Increased plasma methylmalonic acid level does not predict clinical manifestations of vitamin B12 deficiency. Arch Intern Med (2001) 1.63
Immunohistochemical localization of epidermal growth factor in rat and man. Histochemistry (1986) 1.53
Quantitative follow-up of patients with multiple sclerosis using MRI: reproducibility. J Magn Reson Imaging (1999) 1.44
Glucagon-like peptide I receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide I. Diabetes (1996) 1.44
[Homocysteine and cardiovascular disease]. Ugeskr Laeger (2001) 1.39
Role of submandibular saliva and epidermal growth factor in gastric cytoprotection. Gastroenterology (1984) 1.38
[Diagnosis and vitamin B12 deficiency]. Tidsskr Nor Laegeforen (2001) 1.38
Detection of epidermal growth factor-urogastrone and its receptor during fetal mouse development. Proc Natl Acad Sci U S A (1980) 1.35
Schizotypal personality disorder and MRI abnormalities of temporal lobe gray matter. Biol Psychiatry (1999) 1.24
Effect of sialoadenectomy and synthetic human urogastrone on healing of chronic gastric ulcers in rats. Gut (1986) 1.23
Effect of the cobalt-N coordination on the cobamide recognition by the human vitamin B12 binding proteins intrinsic factor, transcobalamin and haptocorrin. Eur J Biochem (1991) 1.22
Gut-homing CD4+ T cell receptor alpha beta+ T cells in the pathogenesis of murine inflammatory bowel disease. Eur J Immunol (1994) 1.21
Molecular dissection of the intrinsic factor-vitamin B12 receptor, cubilin, discloses regions important for membrane association and ligand binding. J Biol Chem (1999) 1.21
Effect of trefoil factors on the viscoelastic properties of mucus gels. Eur J Clin Invest (2002) 1.20
Megalin-mediated endocytosis of transcobalamin-vitamin-B12 complexes suggests a role of the receptor in vitamin-B12 homeostasis. Proc Natl Acad Sci U S A (1996) 1.17
A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients. Cancer Res (2001) 1.15
Isolation of the human placenta receptor for epidermal growth factor-urogastrone. Nature (1979) 1.15
Epidermal growth factor inhibits cysteamine-induced duodenal ulcers. Gastroenterology (1983) 1.15
Pancreatic and intestinal processing of proglucagon in man. Diabetologia (1987) 1.13
Biosynthesis of intestinal microvillar proteins. Role of the Golgi complex and microtubules. Biochem J (1983) 1.11
Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study. Arch Neurol (2001) 1.10
Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon. Gut (2000) 1.08
Influence of epidermal growth factor on liver regeneration after partial hepatectomy in rats. Hepatology (1988) 1.07
Neutralization of Egtved virus pathogenicity to cell cultures and fish by monoclonal antibodies to the viral G protein. J Gen Virol (1990) 1.06
CD4+ T lymphocytes injected into severe combined immunodeficient (SCID) mice lead to an inflammatory and lethal bowel disease. Clin Exp Immunol (1996) 1.05
Quantitation of epidermal growth factor in the rat. Identification and partial characterization of duodenal EGF. Scand J Gastroenterol (1983) 1.05
Volume of blood removed for analytical purposes during hospitalization of low-birthweight infants. Clin Chem (1981) 1.04
Molecular and functional aspects of anionic channels activated during regulatory volume decrease in mammalian cells. Pflugers Arch (2002) 1.04
Vasoactive intestinal polypeptidergic nerves and Brunner's gland secretion in the rat. Gastroenterology (1981) 1.03
Short-term insulin treatment prevents the diabetogenic action of streptozotocin in rats. Endocrinology (1997) 1.03
Solubilization and isolation of the human placenta receptor for epidermal growth factor-urogastrone. J Biol Chem (1980) 1.00
Immunohistochemical localisation and developmental aspects of epidermal growth factor in the rat. Histochemistry (1988) 1.00
Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice. Gut (2004) 1.00
Oral administration of synthetic human urogastrone promotes healing of chronic duodenal ulcers in rats. Gastroenterology (1986) 0.99
C-reactive protein and bacterial meningitis: a meta-analysis. Scand J Clin Lab Invest (1998) 0.98
Implementing the water framework directive in Bulgaria: Integrated river basin management on the Black Sea coast. Water Sci Technol (2005) 0.97
Short bowel patients treated for two years with glucagon-like Peptide 2: effects on intestinal morphology and absorption, renal function, bone and body composition, and muscle function. Gastroenterol Res Pract (2009) 0.97
Health technology assessment in clinical biochemistry. Methylmalonic acid: a Danish showcase. Scand J Clin Lab Invest (2003) 0.96
Substance P and neurokinin A are codistributed and colocalized in the porcine gastrointestinal tract. Peptides (1992) 0.96
Healing of cysteamine-induced duodenal ulcers in the rat. Dig Dis Sci (1985) 0.95
Immunoassays of human trefoil factors 1 and 2: measured on serum from patients with inflammatory bowel disease. Scand J Clin Lab Invest (2004) 0.95
Intestinal growth adaptation and glucagon-like peptide 2 in rats with ileal--jejunal transposition or small bowel resection. Dig Dis Sci (2001) 0.95
Chromosome aberration, sister-chromatid exchange, proliferative rate index, and serum thiocyanate concentration in smokers exposed to low-dose benzene. Environ Mol Mutagen (1994) 0.95
Cysteamine-induced duodenal ulcer and acid secretion in the rat. Scand J Gastroenterol (1980) 0.95
Application of ion-exchange chromatography for the production of human albumin. J Chromatogr (1981) 0.95
The incidence of granulomas in serial sections of rectal biopsies from patients with Crohn's disease. Acta Pathol Microbiol Immunol Scand A (1982) 0.94
Vitamin B-12 treatment has limited effect on health-related quality of life among individuals with elevated plasma methylmalonic acid: a randomized placebo-controlled study. J Intern Med (2003) 0.94
Enzyme-linked immunosorbent assay of epidermal growth factor receptor in lung cancer: comparisons with immunohistochemistry, clinicopathological features and prognosis. Br J Cancer (1998) 0.94
Effect of vasoactive intestinal polypeptide and somatostatin on secretion of epidermal growth factor and bicarbonate from Brunner's glands. Gut (1984) 0.94
The ICln interactome. Acta Physiol (Oxf) (2006) 0.93
Acute effects of smoking during modified sham feeding in duodenal ulcer patients. An analysis of nicotine, acid secretion, gastrin, catecholamines, epidermal growth factor, prostaglandin E2, and bile acids. Scand J Gastroenterol (1993) 0.93
Short-term administration of glucagon-like peptide-2. Effects on bone mineral density and markers of bone turnover in short-bowel patients with no colon. Scand J Gastroenterol (2002) 0.93
Renal origin of rat urinary epidermal growth factor. Regul Pept (1984) 0.93
Conformational changes of transcobalamin induced by aquocobalamin binding. Mechanism of substitution of the cobalt-coordinated group in the bound ligand. J Biol Chem (2000) 0.92
Expression of the epidermal growth factor system in human endometrium during the menstrual cycle. Mol Hum Reprod (2005) 0.92
A meta-analysis of cerebrovascular disease and hyperhomocysteinaemia. Scand J Clin Lab Invest (2000) 0.91
Dipeptidyl peptidase IV inhibition enhances the intestinotrophic effect of glucagon-like peptide-2 in rats and mice. Endocrinology (2000) 0.91
Holotranscobalamin - a sensitive marker of cobalamin malabsorption. Eur J Clin Invest (1999) 0.91
Distribution and metabolism of intravenously administered trefoil factor 2/porcine spasmolytic polypeptide in the rat. Gut (1998) 0.90
Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines. Anticancer Res (2000) 0.90
Short bowel patients treated for two years with glucagon-like peptide 2 (GLP-2): compliance, safety, and effects on quality of life. Gastroenterol Res Pract (2009) 0.90
Characterization of the particulate and soluble acceptor for transcobalamin II from human placenta and rabbit liver. Biochim Biophys Acta (1980) 0.89
The effect of cysteamine on the Brunner gland secretion in the rat. Scand J Gastroenterol (1981) 0.89
Glucagonlike peptide-I-(7-36)-amide receptors only in islets of Langerhans. Autoradiographic survey of extracerebral tissues in rats. Diabetes (1991) 0.89
Immunohistochemical localization of pancreatic spasmolytic polypeptide (PSP) in the pig. Histochemistry (1992) 0.89
Transcobalamin from cow milk: isolation and physico-chemical properties. Biochim Biophys Acta (1996) 0.89
Mucosal surface morphology and histological changes in the duodenum of the rat following administration of cysteamine. Br J Exp Pathol (1977) 0.89
Variation with age of reference values for P-cobalamins. Scand J Haematol (1983) 0.88
Effect of gastrin on liver regeneration after partial hepatectomy in rats. Gut (1990) 0.88
Epidermal growth factor transcription, translation, and signal transduction by rat type II pneumocytes in culture. Am J Respir Cell Mol Biol (1992) 0.88
Molecular cloning and expression in Escherichia coli of the glycoprotein gene of VHS virus, and immunization of rainbow trout with the recombinant protein. J Gen Virol (1993) 0.87
Neurotensin-like immunoreactivity after intestinal resection in the rat. Gut (1987) 0.87
The mechanism of gastrin release in cysteamine-induced duodenal ulcer. Scand J Gastroenterol (1982) 0.87
Unsaturated and cobalamin saturated transcobalamin I and II in normal human plasma. Scand J Clin Lab Invest (1977) 0.87
Vitamin B12 treatment normalizes metabolic markers but has limited clinical effect: a randomized placebo-controlled study. Clin Chem (2001) 0.87
The marker of cobalamin deficiency, plasma methylmalonic acid, correlates to plasma creatinine. J Intern Med (2000) 0.86
Cobalamin binding proteins in human seminal plasma. Scand J Clin Lab Invest (1992) 0.86
Binding of cobalamin and cobinamide to transcobalamin from bovine milk. Biochemistry (1995) 0.86
Synthesis and secretion of a cobalamin-binding protein by HT 29 cell line. Biochem J (1991) 0.86
Immunohistochemical and quantitative changes in salivary EGF, amylase and haptocorrin following radiotherapy for oral cancer. Acta Otolaryngol (1996) 0.86
Quantification of melanoma cell-specific MART-1 mRNA in peripheral blood by a calibrated competitive reverse transcription-PCR. Clin Chem (2000) 0.86
Adrenergic effects on secretion of epidermal growth factor from Brunner's glands. Gut (1985) 0.85
Vasoactive intestinal polypeptide (VIP) in the pig pancreas: role of VIPergic nerves in control of fluid and bicarbonate secretion. Regul Pept (1984) 0.85
Systemic administration of insulin-like growth factor I (IGF-I) causes growth of the rat prostate. J Urol (1997) 0.85
A sensitive enzyme-linked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation, interpretations and limitations. Br J Cancer (1995) 0.85